Global Clinical Microbiology Market to Reach About USD 8.32 billion by 2032, Aided by the Robust Healthcare Sector in North America

North America holds a significant share of the clinical microbiology industry owing to the robust healthcare sector in countries like the United States and Canada. The adoption of the latest diagnostic capabilities in the region is also augmenting the market growth. Moreover, the presence of the microbiological leading research institutes in the region, such as the Massachusetts Institute of Technology and Harvard University, is resulting in the development of various advanced diagnostic technologies, which is propelling the market growth. Meanwhile, Europe is witnessing rapid growth owing to the presence of various major companies in the region. The growing prevalence of infectious diseases, especially among the increasing geriatric population, is leading to a surge in the demand for diagnostic capabilities, which is projected to bolster the growth of the clinical microbiology industry.

bioMérieux SA (OTCMKTS: BMXMF), one of the leading companies in the market, announced that it is expected to distribute Specific Diagnostics’, Reveal Rapid AST System, in Europe in June 2021. The system is based on the company’s unique and patented metabolomic signature technology to provide actionable results for bloodstream infection. This allows either timely de-escalation to focussed, more appropriate, and cost-effective therapies or an effective drug. It also offers consumers the deployment of easy-to-use instruments with a targeted menu, modular design for hospitals, and small footprints while delivering rapid results to enable fully actionable results in order to allow clinicians to diagnose and treat patients quicker and establish a new standard of care. The development of such advanced systems is expected to aid the market growth in the forecast period.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Product, Application, and Region:

• The market, on the basis of product, can be divided into laboratory instruments, microbiology analysers, and reagents.

• Based on application, the industry can be divided into respiratory diseases, bloodstream infections, gastrointestinal diseases, urinary tract infections, sexually transmitted diseases, and periodontal disease, among others.

• The regional markets for clinical microbiology include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The growing emergence of various contagious respiratory diseases is increasing the deployment of clinical microbiology techniques for accurate diagnosis, hence augmenting the market growth.

• The surge of the COVID-19 pandemic and the increasing requirement to diagnose the new mutants of the novel virus is increasing the demand for rapid diagnosis, which is propelling the growth of the clinical microbiology industry.

• The market is being driven by the development of innovative and novel microbiological technologies to surge the efficiency, cost-efficiency, and clinical outcomes of diagnosis.

• The surging quality of healthcare in emerging economies is increasing the requirement for optimal patient management strategies by improving diagnostic capabilities, therefore bolstering the market growth of clinical microbiology.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for clinical microbiology for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the products, applications, and major regions of clinical microbiology.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global clinical microbiology market are bioMérieux SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and Becton, Dickinson and Company, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790